Please enable JavaScript.
Coggle requires JavaScript to display documents.
outline - Coggle Diagram
outline
body
-
atezolizumab with chemotherapy and bevacizumab for first-line treatment of metastatic non-squamous NSCLC(IMpower150 trial (NCT02366143))
-
-
-
-
other on-going ones
phase 1 (in advanced/recurrent ovarian and uterine cancers
-
introduction
-
-
-
current situation
FDA approves atezolizumab for extensive-stage small cell lung cancer Link Title
FDA approves atezolizumab for PD-L1 positive unresectable locally advanced or metastatic triple-negative breast cancer Link Title
FDA approves atezolizumab with chemotherapy and bevacizumab for first-line treatment of metastatic non-squamous NSCLC
-